155 related articles for article (PubMed ID: 25815031)
1. The Prescription Pattern of Chinese Herbal Products Containing Ginseng among Tamoxifen-Treated Female Breast Cancer Survivors in Taiwan: A Population-Based Study.
Hsu WL; Tsai YT; Wu CT; Lai JN
Evid Based Complement Alternat Med; 2015; 2015():385204. PubMed ID: 25815031
[TBL] [Abstract][Full Text] [Related]
2. The use of Chinese herbal products and its influence on tamoxifen induced endometrial cancer risk among female breast cancer patients: a population-based study.
Tsai YT; Lai JN; Wu CT
J Ethnopharmacol; 2014 Sep; 155(2):1256-62. PubMed ID: 25048609
[TBL] [Abstract][Full Text] [Related]
3. The prescription pattern of Chinese herbal products that contain dang-qui and risk of endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan: a population-based study.
Wu CT; Lai JN; Tsai YT
PLoS One; 2014; 9(12):e113887. PubMed ID: 25485843
[TBL] [Abstract][Full Text] [Related]
4. Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study.
Hu YC; Wu CT; Lai JN; Tsai YT
J Ethnopharmacol; 2015 Jul; 169():356-62. PubMed ID: 25934515
[TBL] [Abstract][Full Text] [Related]
5. Prescription pattern of chinese herbal products for breast cancer in taiwan: a population-based study.
Lai JN; Wu CT; Wang JD
Evid Based Complement Alternat Med; 2012; 2012():891893. PubMed ID: 22685488
[TBL] [Abstract][Full Text] [Related]
6. Demographic and medication characteristics of traditional Chinese medicine users among colorectal cancer survivors: A nationwide database study in Taiwan.
Wu CT; Tsai YT; Lai JN
J Tradit Complement Med; 2017 Apr; 7(2):188-194. PubMed ID: 28417089
[TBL] [Abstract][Full Text] [Related]
7. Prescription of Chinese herbal products is associated with a decreased risk of invasive breast cancer.
Tsai YT; Lai JN; Lo PC; Chen CN; Lin JG
Medicine (Baltimore); 2017 Sep; 96(35):e7918. PubMed ID: 28858112
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen Treatment and the Reduced Risk of Hyperlipidemia in Asian Patients With Breast Cancer: A Population-Based Cohort Study.
Lim YP; Lin CL; Lin YN; Ma WC; Hung DZ; Kao CH
Clin Breast Cancer; 2015 Aug; 15(4):294-300. PubMed ID: 25922283
[TBL] [Abstract][Full Text] [Related]
9. Concurrent Use in Taiwan of Chinese Herbal Medicine Therapies among Hormone Users Aged 55 Years to 79 Years and Its Association with Breast Cancer Risk: A Population-Based Study.
Tsai YT; Lai JN; Wu CT; Lin SK
Evid Based Complement Alternat Med; 2014; 2014():683570. PubMed ID: 24987432
[TBL] [Abstract][Full Text] [Related]
10. Prescription pattern of Chinese herbal products for heart failure in Taiwan: A population-based study.
Tsai MY; Hu WL; Lin CC; Lee YC; Chen SY; Hung YC; Chen YH
Int J Cardiol; 2017 Feb; 228():90-96. PubMed ID: 27863367
[TBL] [Abstract][Full Text] [Related]
11. Prescription of Chinese herbal products is associated with a decreased risk of uterine fibroids: A population-based cohort study.
Hsu WC; Tsai YT; Hou YC; Lai JN
Medicine (Baltimore); 2019 Dec; 98(51):e18195. PubMed ID: 31860966
[TBL] [Abstract][Full Text] [Related]
12. Younger tamoxifen-treated breast cancer patients also had higher risk of endometrial cancer and the risk could be reduced by sequenced aromatase inhibitor use: A population-based study in Taiwan.
Chu SC; Hsieh CJ; Wang TF; Hong MK; Chu TY
Ci Ji Yi Xue Za Zhi; 2020; 32(2):175-180. PubMed ID: 32269951
[TBL] [Abstract][Full Text] [Related]
13. Concurrent Use of Conventional Drugs with Chinese Herbal Products in Taiwan: A Population-based Study.
Chen MC; Lai JN; Chen PC; Wang JD
J Tradit Complement Med; 2013 Oct; 3(4):256-62. PubMed ID: 24716186
[TBL] [Abstract][Full Text] [Related]
14. Risk of Endometrial Cancer and Frequencies of Invasive Endometrial Procedures in Young Breast Cancer Survivors Treated With Tamoxifen: A Nationwide Study.
Choi S; Lee YJ; Jeong JH; Jung J; Lee JW; Kim HJ; Ko BS; Son BH; Ahn SH; Lee Y; Chung IY
Front Oncol; 2021; 11():636378. PubMed ID: 34150613
[TBL] [Abstract][Full Text] [Related]
15. Prescription pattern of Chinese herbal products for adult-onset asthma in Taiwan: a population-based study.
Wang HM; Lin SK; Yeh CH; Lai JN
Ann Allergy Asthma Immunol; 2014 May; 112(5):465-70. PubMed ID: 24656660
[TBL] [Abstract][Full Text] [Related]
16. Concurrent Use of Hypnotic Drugs and Chinese Herbal Medicine Therapies among Taiwanese Adults with Insomnia Symptoms: A Population-Based Study.
Lee KH; Tsai YT; Lai JN; Lin SK
Evid Based Complement Alternat Med; 2013; 2013():987862. PubMed ID: 24204397
[TBL] [Abstract][Full Text] [Related]
17. Effect of early use of Chinese herbal products on mortality rate in patients with lung cancer.
Shen HS; Wen SH
J Ethnopharmacol; 2018 Jan; 211():1-8. PubMed ID: 28942131
[TBL] [Abstract][Full Text] [Related]
18. The prescribing of Chinese herbal products in Taiwan: a cross-sectional analysis of the national health insurance reimbursement database.
Hsieh SC; Lai JN; Lee CF; Hu FC; Tseng WL; Wang JD
Pharmacoepidemiol Drug Saf; 2008 Jun; 17(6):609-19. PubMed ID: 18481335
[TBL] [Abstract][Full Text] [Related]
19. The Use of Chinese Herbal Medicine in the Treatment of Chronic Obstructive Pulmonary Disease (COPD).
Liao YN; Hu WL; Chen HJ; Hung YC
Am J Chin Med; 2017; 45(2):225-238. PubMed ID: 28231744
[TBL] [Abstract][Full Text] [Related]
20. Long-Term Use of Tamoxifen Is Associated With a Decreased Subsequent Meningioma Risk in Patients With Breast Cancer: A Nationwide Population-Based Cohort Study.
Sun LM; Lin CL; Sun S; Hsu CY; Shae Z; Kao CH
Front Pharmacol; 2019; 10():674. PubMed ID: 31249531
[No Abstract] [Full Text] [Related]
[Next] [New Search]
